Metronomic Treatment with Low-Dose Trofosfamide Leads to a Long-Term Remission in a Patient with Docetaxel-Refractory Advanced Metastatic Prostate Cancer

The treatment of metastatic prostate cancer patients refractory to androgen withdrawal and docetaxel therapy is currently discouraging and new therapeutic approaches are vastly needed. Here, we report a long-term remission over one year in a 68-year-old patient with metastatic docetaxel-refractory p...

Descripción completa

Detalles Bibliográficos
Autores principales: Greiner, Jochen, Küfer, Rainer, Reske, Sven N., Martin, Volker, Döhner, Hartmut, Ringhoffer, Mark
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853857/
https://www.ncbi.nlm.nih.gov/pubmed/20396674
http://dx.doi.org/10.1155/2010/395720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853857/
https://www.ncbi.nlm.nih.gov/pubmed/20396674
http://dx.doi.org/10.1155/2010/395720

Ejemplares similares